Czechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Fakultní nemocnice Brno
Buyer country
Czechia
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 100%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Chequia – Productos farmacéuticos – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Tsjechië – Farmaceutische producten – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Czechy – Produkty farmaceutyczne – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Tchéquie – Produits pharmaceutiques – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Tschechien – Arzneimittel – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Cechia – Prodotti farmaceutici – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Czechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou USTEKINUMAB II.
What Biderra adds
For notice 592165-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.